Background. Haemodilution has been associated with neurological morbidity in surgical patients. This study tests the hypothesis that inhibition of cerebral vasodilatation by systemic b 2 adrenergic blockade would impair cerebral oxygen delivery leading to tissue hypoxia in severely haemodiluted rats.
neurotransmitters including nitric oxide (NO). 13 Several studies have suggested that perivascular NO-producing neurons play a significant role in regulating CBF in response to a variety of physiological and pharmacological stimuli. 10 14-16 Experimental evidence suggests that NO released from perivascular cerebral neurons is regulated by stimulation of pre-synaptic b 2 adrenergic receptors. 14 17 Stimulation of these b 2 adrenergic receptors releases NO in the region of cerebral blood vessels resulting in cerebral vasodilatation and a regulated increase in CBF. 14 17 The current study tests the hypothesis that b 2 adrenergic mediated cerebral vasodilatation maintains CBF and oxygen delivery after acute haemodilution in rats. Results suggest that systemic b 2 adrenergic blockade attenuated the increase in cerebral cortical oxygen delivery which occurs after severe haemodilution, resulting in a reduction in cerebral tissue oxygen tension. 18 
Materials and methods

Animal model
All animal protocols were approved by the Animal Care and Use Committee at St Michael's Hospital in accordance with the requirements of the Canadian Council on Animal Care. Anaesthesia was induced in male Sprague-Dawley rats (Charles River, St Constant, PQ, Canada) with isoflurane 3-4% in 100% oxygen in an induction chamber and maintained with isoflurane 1-2% (Abbott, St Laurent, PQ, Canada) in 50% oxygen administered via nose cone. After tracheotomy, ventilation was maintained with a pressure-controlled ventilator (Kent Scientific, Litchfield, CT, USA). Cannulation of the right tail vein and tail artery (Angiocath 24G, BD Medical, Oakville ON, Canada) was performed to achieve vascular access for direct measurement of mean arterial blood pressure (MAP) and arterial blood gases (ABGs) and to perform acute haemodilution. ABGs and co-oximetry were performed at baseline (10 min) and after haemodilution (60 min) (Radiometer ALB 500 and OSM 3; London Scientific, London, ON, Canada).
Anaesthetized animals were placed in a stereotaxic frame (ADI Instruments; Harvard Apparatus, Saint Laurent, PQ, Canada), and the scalp was incised sagittally. Bilateral 5 mm diameter burr holes were trephined at the level of the dura, 1-2 mm lateral to the midline and 3-4 mm posterior to the bregma. A combined oxygen sensitive microelectrode, laser Doppler flow probe and temperature probe (OxyLite and OxyFlo; Oxford Optronix, Oxford, UK) was inserted through the dura, 1-2 mm deep into the cerebral cortex or 3-4 mm deep into the hippocampus using stereotaxic coordinates. A heating pad and heating lamp were used to maintain the brain temperature close to 34 C in order to simulate the body temperature of a patient who had suffered from acute blood loss and fluid resuscitation in the operating room.
Experimental protocol
Two groups of animals were studied to determine the physiological effects of b 2 adrenergic antagonism on either hippocampal or parietal cerebral cortical oxygen delivery. Within each group, animals were divided into two arms: the control arm received saline while the experimental arm received the b 2 antagonist. In the hippocampal group, the cerebral probe was placed 3-4 mm past the dura into the region of the hippocampus in both control (n=7) and b 2 antagonist arms (n=6). In the cerebral cortical group, the probe was placed 1-2 mm past the dura into the region of the parietal cerebral cortex in both control (n=9) and b 2 antagonist arms (n=10). These two groups are subsequently referred to as the hippocampal and cerebral cortical groups. Each group contains a saline control and b 2 antagonist arm. Rats were randomly assigned to each of the four arms until n=6 successful cerebral tissue oxygen tension measurements were obtained for each arm. Cerebral tissue oxygen tension measurements were excluded if baseline tissue oxygen tension values were below 5 torr. Cerebral tissue oxygen tension measurements were more difficult to obtain in the cerebral cortical group. Therefore, a larger number of rats were required in each arm of this group.
In all arms, an initial 20 min baseline was established (Baseline #1). At 20 min, either the b 2 adrenergic antagonist (10 mg kg À1 i.v. in 1 ml saline, ICI 118,551, (
obtained from Cedarlane Laboratories Ltd, Hornby, ON) or saline (1 ml) was administered slowly over 10 min. Previous experimental studies demonstrate that the b 2 antagonist ICI 118,551 is capable of crossing the blood-brain barrier. 14 19 20 After b 2 antagonist or saline administration, a second 20 min baseline was established (Baseline #2). All groups were then haemodiluted by simultaneously exchanging 30 ml kg À1 of arterial blood (50% of estimated total blood volume). Blood was withdrawn from the tail artery and replaced with an equivalent volume of warm pentastarch (37 C) via the tail vein (Pentaspan; BristolMyers Squibb Canada Co., St Laurent, PQ, Canada). Volume exchange was performed over 10 min using a programmable 'push-pull' pump (PHD 2000; Harvard Apparatus, St Laurent, PQ, Canada). After completion of haemodilution, physiological measurements were recorded for an additional 60 min. The total duration of the experiment was 120 min. Brain temperature, brain tissue oxygen tension (P Br O 2 ), CBF, brain temperature, MAP and heart rate (HR) were recorded with a computerized data acquisition system (DASYLab 5.6, Kent Scientific, Litchfield, CT, USA). Animals were sacrificed by anaesthetic overdose (ketamine 100 mg i.v.; Parke-Davis, Toronto, ON, Canada).
Statistical analysis
Data from both arms of the hippocampal or cerebral cortical groups were analysed by two-way ANOVA for each individual parameter (Sigma Stat Version 2.03S; Chicago, IL, USA). ABG and co-oximetry data were assessed before and after haemodilution (10 and 60 min). Other physiological measurements were assessed at three individual time points including the initial baseline (Baseline #1, 10 min), 10 min after saline or b 2 antagonist administration (Baseline #2, 40 min) and after haemodilution (Haemodilution, 100 min). Assessments were made for any time, arm or interaction effect for each measured parameter. A post hoc Tukey's test was utilized for post hoc pair-wise comparisons when a significant interaction effect was observed. Statistical significance was assessed at P<0.05. Data were presented as mean (SD). Laser Doppler flow values were normalized to the first baseline and reported as changes relative to Baseline #1 for each animal.
Results
Co-oximetry and arterial blood gas analysis
At baseline, there were no significant differences between any co-oximetry or ABG measurement between the control and b 2 antagonist arms of the hippocampal or cerebral cortical groups. The baseline haemoglobin concentrations were near 125 g litre À1 and blood oxygen contents were near 7.5 mmol litre À1 for all arms (Table 1 ). After haemodilution, there was a significant reduction in haemoglobin concentration (63-71 g litre À1 ) and estimated blood oxygen content (3.7-4.2 mmol litre À1 ) compared with baseline for all arms (Table 1, P<0.001). There was also a small but consistent increase in methaemoglobin concentration by $0.3% in all arms after haemodilution (Table 1, P<0.001). There were no other significant differences in any other parameter after haemodilution (Table 1) .
Haemodynamic and cerebral measurements
Heart rate Initial baseline HRs (Baseline #1) were not statistically different between control and b 2 antagonist arms for either hippocampal or cerebral cortical groups (Fig. 1) . After injection of the b 2 antagonist, the HR tended to be decreased in the b 2 antagonist arm of both hippocampal and cerebral cortical groups, relative to control arms. After haemodilution, there was an increase in HR in both arms of the hippocampal and cerebral cortical groups, relative to baseline (Fig. 1, P<0 .015 and P<0.001, respectively). However, no significant interaction effect was observed for either group (P=0.221 and P=0.136, respectively).
Mean arterial pressure
At Baseline #1 (10 min), Baseline #2 (40 min) and after haemodilution (100 min) there were no differences in mean arterial pressure (MAP) between the control and b 2 antagonist arms in either the hippocampal or cerebral cortical groups (Fig. 1, P=0 .234 and P=0.106, respectively). Upon administration of the b 2 antagonist, there was a transient decrease in MAP during drug administration (data not shown). The MAP then quickly returned to values near to the initial baseline (Fig. 1, 40 min) . In the cerebral cortical group, there was a slight increase in MAP in both arms at 40 and 100 min, relative to Baseline #1 (P<0.05). This effect was not observed in the hippocampal group. No significant interaction effect was observed for the control and b 2 antagonist arms of either the hippocampal or cerebral cortical groups.
Cerebral temperature
The initial baseline hippocampal and cerebral cortical temperatures remained near [33] [34] C in all study arms. In the hippocampal group, there was a significant time effect, with a tendency for temperature to be increased in both saline control and b 2 antagonist arms at 100 min after haemodilution (Fig. 2, P=0 .047). No significant group or interaction effects were observed. In the cerebral cortical group, there was a significant time (P<0.001), arm (P=0.034) and interaction effect (P=0.027) when comparing the b 2 antagonist and saline control arms. Post hoc analysis demonstrates that the cerebral cortical temperature was significantly lower in the b 2 antagonist arm, relative to the saline control group, after haemodilution at 100 min (Fig. 3, P<0 .05). (Fig. 3, P<0 .05).
Normalized regional cerebral blood flow
In both the hippocampal and cerebral cortical groups, the regional cerebral blood flow (rCBF) remained stable over the initial baseline (Baseline #1) and after administration of b 2 antagonist or saline (Baseline #2) (Figs 2 and 3 ). In the hippocampal group, haemodilution resulted in a significant increase in rCBF in both b 2 antagonist and vehicle arms (Fig. 2, P<0 .001). However, there was no difference between the control and b 2 antagonist arms within the hippocampal group at any time (Fig. 2, P=0 .256). In contrast, significant time (P<0.001), arm (P=0.010) and interaction effects (P<0.001) were observed when comparing control and experimental arms in the cerebral cortical group. Post hoc analysis demonstrated that the relative cerebral cortical blood flow was lower in the b 2 antagonist arm [1.4 (0.2) relative to the saline control arm [1.7 (0.2)], after haemodilution at 100 min (Fig. 3, P<0 .05).
Discussion
The present study supports the hypothesis that b 2 adrenergic antagonism impairs parietal cerebral cortical oxygen delivery after acute haemodilution. In the b 2 antagonist treatment arm of the cerebral cortical group, cerebral temperature, tissue oxygen tension and rCBF were all significantly reduced relative to the control arm after haemodilution. These data suggest that the regional cerebral cortical oxygen delivery is maintained by mechanisms which rely upon activation of b 2 adrenoreceptors. Previous haemodilution studies have demonstrated that cerebral cortical oxygen tension was maintained at similar or lower haemoglobin concentrations, in part because of a regulated increase in CBF. 8 9 19 Our data demonstrate that inhibition of cerebral vasodilatation results in reduced cerebral oxygen delivery under similar conditions. Therefore, b 2 adrenoreceptor mediated cerebral vasodilatation likely represents an important regulatory mechanism which acts to maintain adequate cerebral tissue oxygen tension within the cerebral cortex after acute haemodilution.
Interestingly, no effect of b 2 antagonism was observed in the region of the hippocampus. This suggests that b 2 mediated regulation of CBF may be restricted to specific brain regions. Indeed, regional differences in the CBF response to haemodilution have been reported. 11 After severe haemodilution, a much larger absolute increase in blood flow was observed to the visual, auditory, parietal, sensory motor and frontal cortex, relative to that measured in the hippocampus. 11 These regional differences in CBF response may explain why we observed a significant effect of b 2 blockade in the parietal cerebral cortex, but not in the hippocampus. The systemic effect of ICI 118,551 on HR was similar in both groups of rats which received the drug. The HR in treated animals tended to be lower than controls, after ICI 118,551 administration. This trend was maintained throughout the duration of the experiment and is consistent with the observation that HR is under b 2 adrenergic regulation. 21 22 After haemodilution, the HR increased comparably over time in the treatment and control arms of both groups, suggesting that b 2 blockade did not completely inhibit the chronotropic response to haemodilution.
There were no significant differences in MAP when comparing the b 2 antagonist and control arms for either hippocampal or cerebral cortical groups. However, there was a slight reduction in MAP (13%) in both b 2 antagonist treatment arms at 80 min after haemodilution. This could reflect a reduction in cardiac output in the treatment arms of both hippocampal and cerebral cortical groups. Although cardiac output was not measured in the study, previously published experimental studies did not demonstrate a significant impairment in the increase in cardiac output after haemodilution in animals treated with combined b 1 and b 2 antagonists. 23 24 Furthermore, if a reduction in cardiac output was responsible for the observed changes in cerebral cortical blood flow and tissue oxygen tension, then a similar effect should have been observed within the b 2 antagonist treatment arm of the hippocampal group. Such a generalized effect was not observed suggesting that b 2 adrenergic blockade had a specific effect on the cerebral cortical vasculature. Therefore, systemic haemodynamic factors were not likely responsible for the observed region specific effect of b 2 blockade on parietal cerebral cortical blood flow and oxygen delivery.
Physiological studies have demonstrated that b 2 adrenoreceptors may preferentially mediate cerebral vasodilatation in order to re-direct blood flow to the brain in times of physiological stress. 25 26 Severe haemodilution may represent such a stress. The well-characterized increase in CBF observed during acute haemodilution has been attributed to passive changes in blood rheology and active cerebral vasodilatation. [10] [11] [12] However, the mechanisms by which cerebral vasodilatation occur have not been fully characterized. The current study has demonstrated that b 2 adrenoreceptors may participate in the regulation of cerebral cortical vasodilatation during severe haemodilution.
Previous experimental studies have provided evidence that the b 2 antagonist ICI 118,551 is capable of crossing the bloodbrain barrier and can inhibit the regulated increase in CBF in response to nicotine administration. 14 19 20 Therefore, potential sites of action of the b 2 adrenergic antagonist in the study include the vascular smooth muscle, 26 27 vascular endothelium, 28 cerebral neurons 17 29 and astrocytes. 30 Interestingly, NO can mediate cerebral vasodilation by both endothelial dependent and independent mechanisms. 14 17 31 Endothelial dependent mechanisms include b 2 adrenoreceptor mediated up-regulation of endothelial nitric oxide synthase (eNOS) expression. 31 Conversely, endothelial independent mechanisms may regulate CBF by b 2 adrenergic mediated release of NO from perivascular cerebral neurons. 14 17 Additional experimental studies support the hypothesis that increased cerebral cortical neuronal nitric oxide synthase (nNOS) activity may mediate increases in CBF during haemodilution. 10 32 Assessment of relative rCBF utilizing laser Doppler flow probes does not provide an absolute measurement of rCBF. However, laser Doppler has been reported to accurately reflect relative changes in CBF after haemodilution. 9 Therefore, assessment of relative changes of CBF is valid in this model. Our measurements of hippocampal and parietal cerebral cortical tissue oxygen tension demonstrate a higher tissue oxygen tension in the hippocampus. These measurements are consistent with previously published values using similar methodology and may reflect regional heterogeneity in cerebral tissue oxygen tension and metabolism. 9 33 34 The baseline cerebral cortical temperatures tended to be lower than those observed in the hippocampus, possibly because of the closer proximity of the cerebral cortex to the atmosphere. However, no differences were observed between the control and b 2 antagonist arms of the cerebral cortical group at baseline. Immediately after haemodilution with warm pentastarch (37 C), there was a significant increase in brain temperature in the control arms of both the hippocampal and cerebral cortical groups. The maximal temperature was achieved in both groups at about 80 min. The subsequent reduction in temperature may represent redistribution of heat of the infused pentasarch. In the b 2 antagonist arm of the hippocampal group, the increase in brain temperature was blunted but not prevented. However, no increase in brain temperature was observed in the b 2 antagonist arm of the cerebral cortical group. This supports the hypothesis that cerebral cortical vasodilatation was prevented by specific b 2 adrenergic blockade.
In conclusion, our data support the hypothesis that active b 2 mediated cerebral vasodilatation is important in regulating cerebral cortical oxygen delivery in anaesthetized rats after acute haemodilution. Further characterization of the physiological regulation of CBF during haemodilution may help to optimize the management of surgical patients who experience severe acute haemodilution.
